Complex-condition stories, more in progress.
The track with honest limits.
These are the hard ones. Autoimmune, neurologic, post-viral, the conditions where you've likely seen plenty of doctors and heard "we're not sure" more than once. It's our smallest group on purpose: two of our physicians have to agree a case is worth treating before we'll take it on. The people below give you the honest version, what improved, what didn't, and what we still can't fully explain. Nobody here is promising a cure. Watch a few, and you'll hear exactly what that honesty sounds like.
All patient storiesEvaluation-first. Stories, more in progress.
This is the group we say no to most often. Every story here cleared a review by two of our doctors before anyone was treated, and even then, we tell you plainly where it fell short. If you've spent years collecting easy answers that didn't hold up, that honesty might be the part that matters most.
More libraries, same method.
Names marked with (pseudonym) protect patient privacy; composite details reflect outcome patterns we see most often on that indication. Named accounts include written consent for their specific story. Outcome numbers are drawn from our clinical follow-up records; partial and non-responses are reported alongside full responses. We do not compensate patients for their accounts, and we do not ghost-write quotes.
Read the library, then ask about yours.
Stories are pattern. Your case is yours. Your first call is with a Celva patient coordinator; Celva's medical team reads your case.
See if you're a candidate →